TY  - JOUR
AU  - Takacs, Michael
AU  - Frass, Michael
AU  - Pohl-Schickinger, Anja
AU  - Fibert, Philippa
AU  - Lechleitner, Peter
AU  - Oberbaum, Menachem
AU  - Leisser, Ilse
AU  - Panhofer, Peter
AU  - Chandak, Kavita
AU  - Weiermayer, Petra
PY  - 2024
DA  - 2024/08/06
TI  - Use of Homeopathy in Patients Suffering from Long COVID-19 (LONGCOVIHOM): A Case Series
JO  - OBM Integrative and Complementary Medicine
SP  - 045
VL  - 09
IS  - 03
AB  - In some patients, coronavirus (COVID-19) can cause symptoms that last weeks or even months after the infection has gone. Long COVID-19 was defined as a confirmed initial COVID-19 infection, the presence of signs and symptoms more than four weeks after initial infection, and the persistence or appearance of signs and symptoms that another condition cannot explain and did not exist before infection. This study aimed to describe the effect of adjunctive individualized homeopathic treatment delivered to Long COVID-19 patients with previously confirmed symptomatic SARS-CoV-2 infection. Fifteen female consecutive patients with Long COVID-19 were documented. The mean age was 48.5 ± 13.5 (SD) years. The symptoms of Long COVID-19 were diverse. None of the patients showed identical symptoms. All but one patient, hence 93.3%, experienced a timely improvement to complete healing after individualized homeopathic treatment, characterized by modified Naranjo criteria of at least 8 points. The average time until improvement/remission was 47.6 ± 34.6 days, and the median was 37 days. Our observations suggest that adjunctive individualized homeopathic treatment might be considered for patients suffering from Long COVID-19 even with severe long-term sequelae of COVID-19.
SN  - 2573-4393
UR  - https://doi.org/10.21926/obm.icm.2403045
DO  - 10.21926/obm.icm.2403045
ID  - Takacs2024
ER  -